Our hope is that this helps others to get diagnosed early. That it provides courage to fight for their health when they know something is going on in their body, strength to ask the hard questions and not doubt themselves, and peace knowing that they are not walking down this path alone.
Linda Warner-Smithson, on being featured in
“Uncharted: One Woman’s CTCL Story”
Engaging in patient communities
Patient advocacy groups can be a source of great comfort and support to individuals and families struggling with rare or hard-to-treat diseases. They can offer personal connections, real-life experiences and access to educational resources.
Around the world, Kyowa Kirin works with dozens of organizations that provide these services in areas aligned with our portfolio. In North America, we collaborate with and support more than two dozen. We are proud of this work as we know it has a direct impact on the communities we are looking to help.
Often, this means supporting meetings, forums and educational events that enable patients and families to connect and learn from each other. Events like an XLH Kids Camp, where children with X-linked hypophosphatemia met other kids who look like them, often for the first time in their lives.
We invest in disease-awareness and education and work together to make our clinical trials more accessible. Additionally, we focus on research into the needs of patients and caregivers, striving to raise awareness and additional support.
Advocacy groups focused in areas aligned with our portfolio and interested in working with us, should reach out to our advocacy team at patientadvocacy@kyowakirin.com.

For generations, families living with XLH have struggled to explain the disease to many of the professionals involved in their care. Without the data to back them up, patients have often reported feeling dismissed, or that their concerns were not validated. Research projects like this, which focus on the actual lived experiences of someone with XLH, will lead to greater understanding of XLH and facilitate meaningful discussions between XLHers and all those involved in their care.
Susan Faitos, Executive Director of The XLH Network, on the importance of the XLH Community Impact Survey
Driving understanding to effect change
Because insight can lead to greater understanding and support, we work closely with organizations on research about the experiences and needs of patients and families. We also try to connect like-minded groups to create more
impactful change.
Learn more about our work:

Insights for Change: Findings from the XLH Community Impact Survey
A white paper detailing the lived experiences of people living with XLH in the U.S., including its impact on personal finances and physical, mental and social health, as well as access to expert quality care.
The survey, white paper and data report are the result of a collaboration between Kyowa Kirin and The XLH Network and serve as the cornerstone of education and advocacy efforts to increase awareness and galvanize action to address critical gaps in care.

2024 XLH Community Impact Survey
The majority of prior research into the XLH patient experience has focused on the physical symptoms. This report fills this gap by exploring how XLH touches many aspects of life — health, finances and access to expert, quality care. By looking at the experiences of children included in this survey compared to adults, who were likely diagnosed as children, the report illuminates the different eras of XLH care, the progress that has been made and work yet to be done.

Time to Act: A Global Patient-Focused Consensus for Improving the Care of Cutaneous T-cell Lymphoma (CTCL)
A consensus statement from the CTCL Global Care Collaborative, a group of patient advocacy organizations from around the world united by a shared mission to reduce the time to an accurate diagnosis and improve the quality of care and support for people living with CTCL. Kyowa Kirin provided funding to help the group organize and advance its goals.
As a patient organization that interacts with people from around the world, we see firsthand the challenges that our patient community members face navigating their disease. We are proud to join arms with our global patient advocacy colleagues to call attention to changes that we believe will improve the lives of people impacted by cutaneous lymphoma, wherever they live.
Susan Thornton, CEO of the Cutaneous Lymphoma Foundation, on participating in the CTCL Global Care Collaborative
Working together to have a
profound impact
Kyowa Kirin, North America is distinguished by our long-standing commitment and relationships with patient organizations, which are grounded in a shared interest in improving the care experience.


























